Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

1800-272-662
Shopping Cart 0
countryflagAU
Login

Home CompaniesPeak Processing Limited

Peak Processing Limited

Healthcare Drug Manufacturers - Specialty & Generic
PortfolioPortfolio WatchlistWatchlist
Company price
0.014 AUD -0.00 ( 6.67%)
Last update at 2026-11-12T04:28:00Z
VOLUME
352909
Market Cap
20.09M

Momentum Score

…

Peak Processing Limited, together with its subsidiaries, provides cannabis products and services in Canada and the United States. It provides cannabis products, including beverages, hydrocarbon extracts, oils, vapes, topicals, powders, infused flowers, and edibles. The company also offers market insights and analysis, product development, manufacturing, commercialization, distribution, and product rework services. It sells its products through retail stores. The company was formerly known as Althea Group Holdings Limited and change its name to Peak Processing Limited in November 2025. Peak Processing Limited was founded in 2016 and is based in Melbourne, Australia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.01
Low
0.01
High
52 Week Price Range
0.01
Low
0.02
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Peak Processing Limited is an Australian ASX-listed company; publicly available materials give limited detail on its core operations and strategic plan. Long-term growth drivers are not clearly articulated in public filings and will depend on execution of any initiatives disclosed by management. Investors may find the company attractive if management delivers transparent reporting and demonstrates scalable revenue generation.

The primary investment risks are likely small-cap illiquidity, execution and financing risk if the company lacks an established revenue track record.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.01
Dividend Yield
-
Revenue TTM
12.44M
Revenue Per Share
0.01
Gross Profit TTM
0.55M
Debt / Equity
-
ROE
-
Net Debt
-
ROCE
-79.71%
Diluted EPS TTM
-0.01

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Income before tax -4.84M -26.07M -13.72M -12.12M -15.05M
Net income -8.35M -32.06M -13.72M -12.12M -15.05M
Selling general administrative 10.18M 10.72M 23.53M 15.13M 15.58M
Gross profit 7.54M 6.40M 12.93M 9.29M 5.29M
Reconciled depreciation - - - 2.75M 2.01M
Operating income -3.98M -25.06M -11.79M -12.77M -15.40M
Interest expense 0.38M 0.81M 1.50M 0.06M 0.00M
Tax provision 0.00M 0.00M 0.00M 0.00M 0.00M
Interest income 0.73M 1.00M 0.81M 0.01M 0.01M
Net interest income - - - -0.30M -0.18M
Extraordinary items -3.50M -5.98M - - -
Total revenue 15.56M 12.23M 25.13M 20.08M 11.07M
Total operating expenses 19.55M 37.30M 36.92M - -
Cost of revenue 8.03M 5.84M 12.20M 10.78M 5.78M
Total other income expense net - - - 0.94M 0.53M
Net income from continuing ops - - - -12.12M -15.05M
Net income applicable to common shares -8.35M -32.06M -13.72M - -
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Total assets 20.49M 23.65M 48.34M 56.56M 53.85M
Intangible assets 0.01M 0.51M 0.90M 1.58M 2.20M
Total liab 21.06M 23.34M 18.57M 15.12M 11.22M
Total stockholder equity -0.57M 0.31M 29.77M 41.45M 42.70M
Other current liab - - - 0.64M 0.76M
Common stock 93.97M 86.33M 85.34M - -
Capital stock - - - 82.04M 68.05M
Retained earnings -94.19M -85.84M -54.15M -43.48M -40.12M
Good will - 0.00M 17.74M 17.74M 17.74M
Cash 0.53M 0.33M 3.87M 6.21M 6.39M
Total current liabilities 15.49M 16.90M 16.92M 9.77M 6.76M
Short term debt 1.37M 0.97M 3.88M - -
Other stockholder equity -0.36M -0.18M -1.42M - -
Property plant equipment 10.10M 11.55M 13.57M - -
Total current assets 10.30M 10.89M 15.72M 17.78M 14.82M
Long term investments - - - 0.33M 0.35M
Net receivables 5.88M 4.79M 3.85M 6.09M 2.49M
Inventory 2.13M 3.98M 6.20M 3.82M 5.15M
Accounts payable - - - 5.41M 3.23M
Non current assets total - - - 38.79M 39.03M
Capital lease obligations - - - 5.14M 4.05M
Long term debt total 4.61M 5.24M 0.79M - -
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Total cashflows from investing activities 1.08M 2.29M -1.49M - -
Net borrowings - - - 0.02M 0.05M
Total cash from financing activities 7.42M -1.44M 5.55M 9.89M 9.18M
Net income - - - -12.12M -15.05M
Change in cash 0.20M -3.54M -2.33M -0.15M -3.67M
Begin period cash flow - - - 6.39M 10.14M
End period cash flow - - - 6.21M 6.39M
Total cash from operating activities -8.41M -4.39M -6.29M - -
Issuance of capital stock - - - 10.04M 9.27M
Other cashflows from investing activities 2.02M 2.73M - - -
Sale purchase of stock 3.83M 0.12M 1.95M -0.01M -
Other cashflows from financing activities - - 0.00M - -
Capital expenditures 0.94M 0.44M 1.49M 0.98M 2.40M
Change in working capital 0.08M 0.01M 0.04M - -
Free cash flow - - - -10.04M -12.85M

Peer Comparison*

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
PKP
Peak Processing Limited		 -0.00
6.67%		 0.01 - - 1.62 0.53 1.79 -1.80
AFP
Aft Pharmaceuticals Ltd		 0.05
1.41%		 3.60 29.92 18.18 1.48 4.37 2.05 18.56
VLS
Vita Life Sciences Ltd		 0.09
3.42%		 2.72 13.50 42.73 1.52 2.62 1.19 7.17
LGP
Little Green Pharma Ltd		 0.01
16.67%		 0.07 - 10.00 0.64 0.60 1.25 19.47
MVP
Medical Developments International Ltd		 -
-%		 0.44 40.00 166.67 1.06 0.79 0.57 7.45

Profile*

Peak Processing Limited

Peak Processing Limited, together with its subsidiaries, provides cannabis products and services in Canada and the United States. It provides cannabis products, including beverages, hydrocarbon extracts, oils, vapes, topicals, powders, infused flowers, and edibles. The company also offers market insights and analysis, product development, manufacturing, commercialization, distribution, and product rework services. It sells its products through retail stores. The company was formerly known as Althea Group Holdings Limited and change its name to Peak Processing Limited in November 2025. Peak Processing Limited was founded in 2016 and is based in Melbourne, Australia.

180 Lonsdale Street, Melbourne, VIC, Australia, 3000

61 3 7044 2936

https://peakprocessing.com

Name Title Year Born
Mr. Brian Mbesha Chief Financial Officer NA
Mr. David Sauer General Counsel NA
Mr. Adam Gallagher Company Secretary NA
Mr. Barry Katzman M.B.A. MD, CEO & Director NA
Mr. Ian Scott Chief Operating Officer NA
Mr. Graham Hamilton Director of Marketing & Commercial NA
Ms. Amy Kelly Vice President of Human Resources & Global Culture NA
Mr. Prince Adjei Senior Vice President of Plant Operations NA
Ms. Amy Kelly Chief Administrative Officer NA
Mr. Zakary Fleisher Sharbanee Executive Director NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

CU6
AUD 2.05
+23.49%
DMP
AUD 25.06
+12.93%
G6M
AUD 2.74
+10.93%
XRO
AUD 75.17
+6.08%
SGR
AUD 0.17
+6.06%
AXQ
AUD 3.07
-18.35%
BOE
AUD 1.50
-9.39%
GQG
AUD 0.71
-8.97%
MI6
AUD 0.81
-8.52%
ELV
AUD 3.73
-8.35%

Equity Sectors*

  • Basic Materials

    -3.09%

  • Communication Services

    +0.75%

  • Consumer Cyclical

    +0.43%

  • Consumer Defensive

    +0.12%

  • Energy

    -1.07%

  • Financial Services

    -0.02%

  • Healthcare

    +1.08%

  • Industrials

    -0.22%

  • Real Estate

    +0.61%

  • Technology

    -1.69%

  • Utilities

    -0.18%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…